Which factors influence onset and latency to treatment in generalized anxiety disorder, panic disorder, and obsessive–compulsive disorder?
Authors:
- Beatrice BenattiBBBeatrice Benatti
- Giulia CamuriGCGiulia Camuri
- Bernardo Dell’ossoBDBernardo Dell’osso
- Laura CremaschiLCLaura Cremaschi
- Ester SembiraESEster Sembira
- Carlotta PalazzoCPCarlotta Palazzo
- Lucio OldaniLOLucio Oldani
- Cristina DobreaCDCristina Dobrea
- Chiara AriciCAChiara Arici
- Diego PrimaveraDPDiego Primavera
- Bernardo CarpinielloBCBernardo Carpiniello
- Filippo CastellanoFCFilippo Castellano
- 1 November 2016
- journal article
- research article
- Published by Wolters Kluwer Health in International Clinical Psychopharmacology
- Vol. 31 (6) , 347-352
Abstract
Anxiety disorders are common, comorbid, and disabling conditions, often underdiagnosed and under-treated, typically with an early onset, chronic course, and prolonged duration of untreated illness. The present study aimed to explore the influence of sociodemographic and clinical factors in relation to onset and latency to treatment in patients with generalized anxiety disorder (GAD), panic disorder (PD), and obsessive-compulsive disorder (OCD). A total of 157 patients with a Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Text Revision (DSM-IV-TR) diagnosis of PD (n=49), GAD (n=68), and OCD (n=40) were recruited, and epidemiological and clinical variables were collected through a specific questionnaire. Statistical analyses were carried out to compare variables across diagnostic groups. PD, GAD, and OCD patients showed a duration of untreated illness of 53.9±81.5, 77.47±95.76, and 90.6±112.1 months, respectively. Significant differences between groups were found with respect to age, age of first diagnosis, age of first treatment, family history of psychiatric illness, onset-related stressful events, benzodiazepine prescription as first treatment, antidepressant prescription as first treatment, and help-seeking (self-initiated vs. initiated by others). Patients with GAD, PD, and OCD showed significant differences in factors influencing onset and latency to treatment, which may, in turn, affect condition-related outcome and overall prognosis. Further studies with larger samples are warranted in the field.Keywords
This publication has 39 references indexed in Scilit:
- Admixture analysis of age at symptom onset and age at disorder onset in a large sample of patients with obsessive–compulsive disorderJournal of Affective Disorders, 2015
- Health anxiety and hypochondriasis in the light of DSM-5Anxiety, stress, and coping, 2015
- Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for PsychopharmacologyJournal of Psychopharmacology, 2014
- Duration of Untreated Illness and Duration of Illness in Anxiety Disorders: Assessment and Influence on Outcome2013
- Guidelines for the pharmacological treatment of anxiety disorders, obsessive–compulsive disorder and posttraumatic stress disorder in primary careInternational Journal of Psychiatry in Clinical Practice, 2012
- An international survey of reported prescribing practice in the treatment of patients with generalised anxiety disorderThe World Journal of Biological Psychiatry, 2011
- Age at onset and latency to treatment (duration of untreated illness) in patients with mood and anxiety disorders: a naturalistic studyInternational Clinical Psychopharmacology, 2010
- Incidence and Risk Patterns of Anxiety and Depressive Disorders and Categorization of Generalized Anxiety DisorderArchives of General Psychiatry, 2010
- First-Line Pharmacotherapy Approaches for Generalized Anxiety DisorderThe Journal of Clinical Psychiatry, 2009
- Defining, operationalizing and measuring the duration of untreated psychosis: advances, limitations and future directionsEarly Intervention in Psychiatry, 2007